Legend Biotech (LEGN) Other Non Operating Income (2020 - 2025)

Legend Biotech's Other Non Operating Income history runs 6 years deep, the most recent figure standing at -$2.4 million for Q4 2025.

• Quarterly Other Non Operating Income fell 102.15% year-over-year to -$2.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$55.0 million (down 149.15% YoY) and the FY2025 annual result came in at -$164.8 million, down 247.41% from the prior year.
• Other Non Operating Income was -$2.4 million for Q4 2025 at Legend Biotech, down from $354000.0 in the prior quarter.
• Across five years, Other Non Operating Income topped out at $111.4 million in Q4 2024 and bottomed at -$108.1 million in Q2 2025.
• A 5-year average of $3.6 million and a median of $2.4 million in 2021 frame the typical range for Other Non Operating Income.
• Peak annual rise in Other Non Operating Income reached 47372.73% in 2021, while the deepest fall reached 3437.55% in 2021.
• Legend Biotech's Other Non Operating Income stood at $31.2 million in 2021, then slumped by 129.81% to -$9.3 million in 2022, then surged by 208.07% to $10.1 million in 2023, then surged by 1008.43% to $111.4 million in 2024, then plunged by 102.15% to -$2.4 million in 2025.
• Business Quant data shows LEGN's Other Non Operating Income at -$2.4 million in Q4 2025, $354000.0 in Q3 2025, and -$108.1 million in Q2 2025.